...
首页> 外文期刊>Critical reviews in oncology/hematology >Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysis
【24h】

Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysis

机译:我们是否准备好从高剂量常规转移到中度风险前列腺癌中等高次次次次次级放射疗法? 试验顺序分析对随机对照试验的系统综述

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: to evaluate efficacy and late toxicity of moderate hypofractionated (HFRT) over high-dose (>= 76 Gy) conventional radiotherapy (CRT) in a non-inferiority perspective.
机译:目的:以非劣级度的观点评估高剂量(> = 76GY)常规放射治疗(CRT)的中度低次级(HFRT)的疗效和晚期毒性。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号